MOLM-13 Cells
690,00 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | The MOLM-13 cell line is a human acute myeloid leukemia (AML) cell line, originally derived from a patient diagnosed with AML-M5a (acute monocytic leukemia, FAB classification). This line was established at the time of disease relapse, following prior progression from myelodysplastic syndrome (MDS). MOLM-13 cells harbor the MLL-AF9 gene fusion resulting from an insertion, ins(11;9)(q23;p22p23), and exhibit additional chromosomal abnormalities such as trisomy 8, a common feature associated with AML. In terms of phenotypic characteristics, MOLM-13 cells express myeloid and monocyte-associated markers including CD33, CD13, and CD15. However, they lack expression of CD34, a marker of hematopoietic stem and progenitor cells, distinguishing them from other leukemia subtypes. MOLM-13 cells also display monoblastoid morphology with fine chromatin and prominent nucleoli. Functionally, they are capable of differentiation into macrophage-like cells upon exposure to specific cytokines such as interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α), which also enhance expression of myelomonocytic markers. MOLM-13 serves as a critical model for studying leukemogenesis, particularly mechanisms underlying MLL-rearranged leukemias. It is also widely used in preclinical research, including the evaluation of novel therapies such as CD70-specific CAR-T cells, which have demonstrated efficacy against MOLM-13 in vitro and in xenograft models. This makes MOLM-13 an invaluable tool for exploring targeted therapeutic approaches for high-risk AML. |
|---|---|
| Organisme | Human |
| Tissu | Peripheral blood |
| Maladie | Adult acute myeloid leukemia |
| Synonymes | MOLM13, Molm13, Molm 13 |
Caractéristiques
| Âge | 20 years |
|---|---|
| Genre | Male |
| Origine ethnique | Japanese |
| Morphologie | Lymphoblast-like |
| Propriétés de croissance | Suspension |
Données réglementaires
| Référence | MOLM-13 (Cytion catalog number 305393) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | CVCL_2119 |
Données biomoléculaires
| Expression de l'antigène | CD3 -, CD4 +, CD14 -, CD15 +, CD19 -, CD33 +, CD34 -, cy CD68 +, HLA-DR - |
|---|---|
| Profil mutationnel | Mutation: FLT3, unexplicit, internal tandem duplication; Gene fusion: KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 |
Manipulation
| Milieu de culture | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suppléments | Supplement the medium with 10% FBS |
| Densité de semis | Maintain culture between 4 x 105 to 2 x 106 cells/mL |
| Renouvellement des fluides | 2 to 3 times per week |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 305393-261225 | Certificat d'analyse | 11. Feb. 2026 | 305393 |